Study of Dasatinib in Patients With Advanced Solid Tumors
Clinical trial NCT00162214 · TERMINATED
Trial details
- NCT number
- NCT00162214
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.